Boehringer Ingelheim (Germany)

Profile subscribers click here for full profile

Boeheringer Ingelheim is a sizeable German pharmaceutical company with a growing presence in the US and other international markets. Its top-selling product is Spiriva, a treatment for pulmonary disease, with sales of €3.6bn in 2015. Other key pharmaceutical brands include anticoagulant Pradaxa and Micardis for high blood pressure (both $1bn-plus products), and diabetes drugs Trajenta and Jardiance. The group also currently has a significant OTC business, especially in Europe, with respiratory and intenstinal brands such as Buscopan, Dulcolax and Mucosolvan and Pharmaton vitamins. In 2016, it agreed to transfer this business to Sanofi and paid an additional €4.7bn to acquire the latter's substantial animal healthcare division Merial. Combined with its existing operations in this sector (previously known as Fort Dodge Animal Health), Boehringer will become the world's second largest specialits in this market behind Zoetis. Boehringer reported worldwide revenues of €14.8bn in 2015. The group was founded in 1885 by Andreas Boehringer and was run by members of the family until the early 1990s. It is still privately owned by them. Andreas Barner is executive chairman. Christian Boehringer chairs the supervisory board, which also comprises four other family members. Adbrands does not currently profile this company but subscribers may access account assignments and contact information. The searchable account assignments database is available to full subscribers to premium services. Click here to access Adbrands account assignments (subscribers only); or see here for information on how to subscribe.

Which agencies handle advertising for Boehringer Ingelheim? Find out more from Adbrands Account Assignments

Who are the competitors of Boehringer Ingelheim? See Pharmaceutical Sector index for other companies

Capsule checked 7th July 2016

Recent stories from Adbrands Weekly Update:

Adbrands Weekly Update 7th July 2016: Sanofi agreed terms to transfer ownership of its animal health division Merial to German counterpart Boehringer Ingelheim, in return for the latter's OTC healthcare unit and €4.7bn in cash. Once that deal completes later this year, Boehringer will become the world's second largest animal health company behind Zoetis with sales of around €3.8bn. Sanofi's enlarged consumer healthcare division would have sales in excess of €4.9bn.

Adbrands Weekly Update 17th Dec 2015: Yet another deal is in the offing to reshape the landscape of the global pharmaceutical industry. French pharma giant Sanofi and Germany's family-controlled Boehringer Ingelheim are reported to be in "exclusive negotiations" for a major potential asset swap. Sanofi is proposing the transfer of its animal health division Merial to its German rival to create a new #2 in that sector behind Zoetis. In return, it would receive €4.7bn in cash as well as Boehringer's consumer health division in all markets except China. The addition of products such as the laxative Dulcolax, Pharmaton vitamins and cough remedies Bisolvon and Mucosolvan, would boost Sanofi's OTC revenues to around €5.1bn, pushing it into the global #3 position behind GSK and Bayer.

Adbrands Company Profiles assess more than 1,000 leading advertisers, brands and agencies, and examine each company's business record, geographic strength and comparative performance within its chosen sector, including strengths and weaknesses, history, up-to-date news and top-line financial information. What else does the company do? How did it originate? What other brands does it own? How is it performing in the market? With what other businesses is it affiliated? 

Adbrands Account Assignments is a database tracking account management for the world's leading brands and companies. In other words, which advertising agency handles which accounts in which countries. Fully searchable by brand, brandowner company or advertising agency, the database now contains more than 15,000 worldwide account assignments for over 4,000 leading brands.

More about Company Profiles | More about Account Assignments

New to the industry? See here for a brief summary of how the agency business is structured.

Subscribe to to access the full profile and account assignments

All rights reserved © Mind Advertising Ltd 1998-2018